Improved discrimination of prostate cancer and benign prostatic hyperplasia by means of the quotient of free and total PSA.
- 1 January 1999
- journal article
- Published by Springer Nature in International Urology and Nephrology
- Vol. 31 (3) , 351-359
- https://doi.org/10.1023/a:1007178203861
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- RATIO OF FREE-TO-TOTAL PROSTATE SPECIFIC ANTIGEN IN SERUM CANNOT DISTINGUISH PATIENTS WITH PROSTATE CANCER FROM THOSE WITH CHRONIC INFLAMMATION OF THE PROSTATEJournal of Urology, 1998
- Free/total serum prostate‐specific antigen ratio: how helpful is it in detecting prostate cancer?British Journal of Urology, 1998
- Impact of free prostate-specific antigen on discordant measurement results of assays for total prostate-specific antigenUrology, 1996
- The clinical usefulness of percent free-PSAUrology, 1996
- Free to total Prostate-Specific Antigen (PSA) ratio improves the discrimination between prostate cancer and benign prostatic hyperplasia (BPH) in the diagnostic gray zone of 1.8 to 10 ng/mL total PSAUrology, 1996
- Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: Influence of total psa, prostate volume, and ageUrology, 1996
- Stability of free prostate-specific antigen in serum samples under a variety of sample collection and sample storage conditionsUrology, 1996
- A comparison of the free fraction of serum prostate specific antigen in men with benign and cancerous prostatesJournal of Urology, 1996
- Clinical significance of the determination of noncomplexed prostate-specific antigen as a marker for prostate carcinomaUrology, 1996
- The value of screening tests in the detection of prostate cancer. Part I: Results of a retrospective evaluation of 1726 menUrology, 1995